Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
almost killed him; This spontaneous case was reported by a physician and describes the occurrence of NEAR DEATH EXPERIENCE (almost killed him) in a male patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEAR DEATH EXPERIENCE (almost killed him) (seriousness criterion medically significant). At the time of the report, NEAR DEATH EXPERIENCE (almost killed him) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. It was stated reporter was trying to find someone that offered the Novavax Covid vaccine and he could not find anyone. In other places, he was unable to find it. He was worried about Covid because it was rising to epidemic levels again and it has a real bad impact on him. Patient might like to be vaccinated on this weekend. It was reported that there were 2 seasons for Covid; one was when it was too hot and everyone was inside under the air conditioning, and the other was when it was too cold and people were hiding, and during that time, it was summer season in the reporter's place. It was reported that he did not like the mRNA vaccines and it was reported that Moderna almost killed him, and several of his friends stroke out in different things as well as it seemed to be not very effective. Patient would prefer to be vaccinated with Novavax Covid vaccine or he might would have Pfizer vaccine. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2025-788613 (E2B Linked Report).; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-788613:invalid case for multiple patients